Factors Associated with Length of Hospital Stay among COVID-19 Patients in Saudi Arabia: A Retrospective Study during the First Pandemic Wave
Abdullah K Alahmari, Ziyad S Almalki, Ahmed A Albassam, Mohammed M Alsultan, Ahmed M Alshehri, Nehad J Ahmed, Abdulhadi M Alqahtani
Healthcare, doi:10.3390/healthcare10071201
The COVID-19 pandemic severely affected healthcare systems and tested their preparedness. To date, the length of hospital stay (LoHS) and its factors among COVID-19 patients has not been thoroughly studied. Moreover, it is essential to identify the features of these patients. Adult COVID-19 patients in Saudi Arabia with complete electronic medical records and who were hospitalised for >1 day between 1 May 2020 and 30 July 2020 at one of two hospitals were considered for this retrospective cohort study. Descriptive statistics and multivariate generalized linear models were performed using the data. Of the patients, 34% were ≥50 years old and 80.14% were female. More than 70% had mild-to-moderate symptoms; 45% had either diabetes or hypertension. The median LoHS was 7.00 days (IQR: 3-11). Patients who were females, had either critical or severe disease, were on mechanical ventilation, had diabetes, and administered ceftriaxone had significantly longer LoHS (p < 0.05). Patients administered zinc sulphate had significantly shorter LoHS (p = 0.0008). During the first pandemic wave, COVID-19 patients were hospitalised for 7 days. Healthcare professionals should pay more attention to women, patients with diabetes, and those with severe or critical symptoms. Unnecessary use of ceftriaxone should be minimised, and zinc sulphate can be administered.
References
Abate, Kassie, Kassaw, Aragie, Masresha, Sex Difference in Coronavirus Disease (COVID-19): A Systematic Review and Meta-Analysis, BMJ Open,
doi:10.1136/bmjopen-2020-040129Abougazia, Alnuaimi, Mahran, Ali, Khedr et al., Chest X-ray Findings in COVID-19 Patients Presenting to Primary Care during the Peak of the First Wave of the Pandemic in Qatar: Their Association with Clinical and Laboratory Findings, Pulm. Med,
doi:10.1155/2021/4496488Adebisi, Jimoh, Ogunkola, Uwizeyimana, Olayemi et al., The Use of Antibiotics in COVID-19 Management: A Rapid Review of National Treatment Guidelines in 10 African Countries, Trop. Med. Health,
doi:10.1186/s41182-021-00344-wAlghamdi, Clinical Characteristics and Treatment Outcomes of severe (ICU) COVID-19 patients in Saudi Arabia: A Single Centre Study, Saudi Pharm. J,
doi:10.1016/j.jsps.2021.08.008Alguwaihes, Al-Sofiani, Megdad, Albader, Alsari et al., Diabetes and COVID-19 among Hospitalized Patients in Saudi Arabia: A Single-Centre Retrospective Study, Cardiovasc. Diabetol,
doi:10.1186/s12933-020-01184-4Alharbi, Alqahtani, Albalawi, Bakouri, Epidemiological Modeling of COVID-19 in Saudi Arabia: Spread Projection, Awareness, and Impact of Treatment, Appl. Sci,
doi:10.3390/app10175895Alharthy, Aletreby, Faqihi, Balhamar, Alaklobi et al., Clinical Characteristics and Predictors of 28-day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study, J. Epidemiol. Glob. Health,
doi:10.2991/jegh.k.200928.001Alqahtani, Almalki, Alalweet, Almazrou, Alanazi et al., Assessing the Severity of Illness in Patients with Coronavirus Disease in Saudi Arabia: A Retrospective Descriptive Cross-Sectional Study, Front. Public Health,
doi:10.3389/fpubh.2020.593256Alqassieh, Bsisu, Al-Sabbagh, El-Hammuri, Yousef et al., Clinical Characteristics and Predictors of the Duration of Hospital Stay in COVID-19 Patients in Jordan [version 1; peer review: 1 approved with reservations, 1 not approved,
doi:10.12688/f1000research.27419.1Alsofayan, Althunayyan, Khan, Hakawi, Assiri, Clinical Characteristics of COVID-19 in Saudi Arabia: A National Retrospective Study, J. Infect. Public Health,
doi:10.1016/j.jiph.2020.05.026Alwafi, Naser, Qanash, Brinji, Ghazawi et al., Predictors of Length of Hospital Stay, Mortality, and Outcomes among Hospitalised COVID-19 Patients in Saudi Arabia: A Cross-Sectional Study, J. Multidiscip. Healthc,
doi:10.2147/JMDH.S304788Billett, Reyes-Gil, Szymanski, Ikemura, Stahl et al., Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality, Thromb. Haemost,
doi:10.1055/s-0040-1720978Cai, Xu, Lin, Yang, Xu et al., A Case Series of Children with 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features, Clin. Infect. Dis,
doi:10.1093/cid/ciaa198Chedid, Waked, Haddad, Chetata, Saliba et al., Antibiotics in Treatment of COVID-19 Complications: A Review of Frequency, Indications, and Efficacy, J. Infect. Public Health,
doi:10.1016/j.jiph.2021.02.001Chen, Zhang, Yang, Wang, Zhai et al., Fangcang Shelter Hospitals: A Novel Concept for Responding to Public Health Emergencies, Lancet,
doi:10.1016/S0140-6736(20)30744-3Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study, Lancet
Chitungo, Dzinamarira, Nyazika, Herrera, Musuka et al., Inappropriate antibiotic use in Zimbabwe in the COVID-19 Era: A perfect recipe for antimicrobial resistance, Antibiotics,
doi:10.3390/antibiotics11020244Dowd, Andriano, Brazel, Rotondi, Block et al., Demographic Science Aids in Understanding the Spread and Fatality Rates of COVID-19,
doi:10.1073/pnas.2004911117Estrada, Calderón Parra, Fernández Carracedo, Muiño Míguez, Ramos Martínez et al., Inadequate use of antibiotics in the COVID-19 era: Effectiveness of antibiotic therapy, BMC Infect. Dis,
doi:10.1186/s12879-021-06821-1Guo, Lu, Tan, Kuang, Luo et al., Risk Factors on Admission Associated with Hospital Length of Stay in Patients with COVID-19: A Retrospective Cohort Study, Sci. Rep,
doi:10.1038/s41598-021-86853-4Jin, Bai, He, Wu, Liu et al., Gender Differences in Patients with COVID-19: Focus on Severity and Mortality, Front. Public Health,
doi:10.3389/fpubh.2020.00152Jombart, Procter, Knight, COVID-19 Length of Hospital Stay: A Systematic Review and Data Synthesis, BMC Med
Killerby, Link-Gelles, Haight, Schrodt, England et al., Characteristics Associated with Hospitalization Among Patients with COVID-19-Metropolitan Atlanta, Georgia, Morb. Mortal. Wkly. Rep,
doi:10.15585/mmwr.mm6925e1Leal, Yu, Chen, Fedele, Martins, Paracetamol is Associated with a Lower Risk of COVID-19 Infection and Decreased ACE2 Protein Expression: A Retrospective Analysis, COVID,
doi:10.3390/covid1010018Mahboub, Al Bataineh, Alshraideh, Hamoudi, Salameh et al., Prediction of COVID-19 Hospital Length of Stay and Risk of Death Using Artificial Intelligence-Based Modeling, Front. Med,
doi:10.3389/fmed.2021.592336Petrosillo, Viceconte, Ergonul, Ippolito, Petersen, COVID-19, SARS and MERS: Are They Closely Related?, Clin. Microbiol. Infect,
doi:10.1016/j.cmi.2020.03.026Phua, Weng, Ling, Egi, Lim et al., Intensive Care Management of Coronavirus Disease 2019 (COVID-19): Challenges and Recommendations, Lancet Respir. Med,
doi:10.1016/S2213-2600(20)30161-2Rees, Nightingale, Jafari, Waterlow, Clifford et al., None
Sanyaolu, Okorie, Marinkovic, Patidar, Younis et al., Comorbidity and its impact on patients with COVID-19, SN Compr. Clin. Med,
doi:10.1007/s42399-020-00363-4Singh, Malik, Patel, Pothuru, Israni et al., Kidney disease and COVID-19 disease severity-Systematic review and meta-analysis, Clin. Exp. Med,
doi:10.1007/s10238-021-00715-xSkalny, Rink, Ajsuvakova, Aschner, Gritsenko et al., Zinc and Respiratory Tract Infections: Perspectives for COVID19 (Review), Int. J. Mol. Med
Tang, Bai, Chen, Gong, Li et al., Anticoagulant Treatment is Associated with Decreased Mortality in Severe Coronavirus Disease 2019 Patients with Coagulopathy, J. Thromb. Haemostasis,
doi:10.1111/jth.14817Tenforde, Rose, Lindsell, Shapiro, Files et al., Characteristics of Adult Outpatients and Inpatients with COVID-19-11 Academic Medical Centers, Morb. Mortal. Wkly. Rep,
doi:10.15585/mmwr.mm6926e3Vekaria, Overton, Wiśniowski, Ahmad, Aparicio-Castro et al., Hospital Length of Stay for COVID-19 Patients: Data-Driven Methods for Forward Planning, BMC Infect. Dis,
doi:10.1186/s12879-021-06371-6Verity, Okell, Dorigatti, Winskill, Whittaker et al., Estimates of the Severity of Coronavirus Disease 2019: A Model-Based Analysis, Lancet Infect. Dis,
doi:10.1016/S1473-3099(20)30243-7Wang, Liu, Wei, Ji, Liu et al., What are the Risk Factors of Hospital Length of Stay in the Novel Coronavirus Pneumonia (COVID-19) Patients? A Survival Analysis in Southwest China, PLoS ONE,
doi:10.1371/journal.pone.0261216Who, Coronavirus Disease (COVID-19) Advice for the Public: Mythbusters
Worldometer, None
Wu, Mcgoogan, Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention, J. Am. Med. Assoc,
doi:10.1001/jama.2020.2648Yasui, Yasui, Suzuki, Saitou, Yamamoto et al., Analysis of the Predictive Factors for a Critical Illness of COVID-19 During Treatment-Relationship between Serum Zinc Level and Critical Illness of COVID-19, Int. J. Infect. Dis,
doi:10.1016/j.ijid.2020.09.008Zhou, Yu, Du, Fan, Liu et al., Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study, Lancet
Álvarez-Esteban, Del Barrio, Rueda, Rueda, Predicting COVID-19 Progression from Diagnosis to Recovery or Death Linking Primary Care and Hospital Records in Castilla y León (Spain), PLoS ONE,
doi:10.1371/journal.pone.0257613
